1. Metabolic Enzyme/Protease
  2. Cytochrome P450
  3. Flavanone

Flavanone  (Synonyms: 黄烷酮)

目录号: HY-N7128 纯度: 99.84%
COA 产品使用指南

Flavanone 是一种天然的黄酮类化合物。Flavanone 对人类雌激素合成酶芳香化酶 (aromatase) 具有抑制作用。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Flavanone Chemical Structure

Flavanone Chemical Structure

CAS No. : 487-26-3

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
Free Sample (0.1 - 0.2 mg)   Apply now  
10 mM * 1 mL in DMSO ¥110
In-stock
100 mg ¥100
In-stock
500 mg ¥200
In-stock
1 g   询价  
5 g   询价  

* Please select Quantity before adding items.

Customer Review

Other Forms of Flavanone:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Flavanone is a naturally occurring flavone. Flavanone has inhibitory activity for human estrogen synthetase (aromatase)[1].

IC50 & Target

Aromatase

 

细胞效力
(Cellular Effect)
Cell Line Type Value Description References
A549 IC50
14.2 μg/mL
Compound: 2-phenylchroman-4-one
Antiproliferative activity against A549 cells after 72 hrs by MTT assay
Antiproliferative activity against A549 cells after 72 hrs by MTT assay
[PMID: 17137679]
Bel-7402 IC50
> 50 μg/mL
Compound: 2-phenylchroman-4-one
Antiproliferative activity against Bel7402 cells after 72 hrs by MTT assay
Antiproliferative activity against Bel7402 cells after 72 hrs by MTT assay
[PMID: 17137679]
BTI-TN-5B1-4 IC50
2.87 μM
Compound: 2a, racemic
Inhibition of human recombinant MAOB expressed in BTI-TN-5B1-4 cells by para-tyramine oxidation assay
Inhibition of human recombinant MAOB expressed in BTI-TN-5B1-4 cells by para-tyramine oxidation assay
[PMID: 20045650]
ECa-109 cell line IC50
27.7 μg/mL
Compound: 2-phenylchroman-4-one
Antiproliferative activity against ECA109 cells after 72 hrs by MTT assay
Antiproliferative activity against ECA109 cells after 72 hrs by MTT assay
[PMID: 17137679]
H9 IC50
45 μM
Compound: 17
Cytotoxicity against human H9 cells after 3 days
Cytotoxicity against human H9 cells after 3 days
[PMID: 8158164]
H9 EC50
58 μM
Compound: 17
Antiviral activity against HIV1 3B infected in human H9 cells assessed as inhibition of viral replication after 3 days by p24 antigen capture assay
Antiviral activity against HIV1 3B infected in human H9 cells assessed as inhibition of viral replication after 3 days by p24 antigen capture assay
[PMID: 8158164]
HL-60 IC50
3.4 μg/mL
Compound: 2-phenylchroman-4-one
Antiproliferative activity against HL60 cells after 72 hrs by MTT assay
Antiproliferative activity against HL60 cells after 72 hrs by MTT assay
[PMID: 17137679]
HL-60 IC50
51.1 μM
Compound: Flavanone
Cytotoxicity against human HL60 cells assessed as reduction in cell survival after 46 hrs by MTT assay
Cytotoxicity against human HL60 cells assessed as reduction in cell survival after 46 hrs by MTT assay
[PMID: 27234147]
HL-60 IC50
51.1 μM
Compound: Flavanone
Cytotoxicity against human HL60 cells after 46 hrs by MTT assay
Cytotoxicity against human HL60 cells after 46 hrs by MTT assay
[PMID: 23756061]
HL-60 IC50
51.1 μM
Compound: Flavanone
Cytotoxicity against human HL60 cells by MTT assay
Cytotoxicity against human HL60 cells by MTT assay
[PMID: 25091929]
MCF7 IC50
> 25 μg/mL
Compound: 2-phenylchroman-4-one
Antiproliferative activity against MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against MCF7 cells after 72 hrs by MTT assay
[PMID: 17137679]
NALM-6 IC50
57.6 μM
Compound: Flavanone
Cytotoxicity against human NALM6 cells after 46 hrs by MTT assay
Cytotoxicity against human NALM6 cells after 46 hrs by MTT assay
[PMID: 23756061]
NALM-6 IC50
57.6 μM
Compound: Flavanone
Cytotoxicity against human NALM6 cells by MTT assay
Cytotoxicity against human NALM6 cells by MTT assay
[PMID: 25091929]
PC-3 IC50
16.6 μg/mL
Compound: 2-phenylchroman-4-one
Antiproliferative activity against PC3 cells after 72 hrs by MTT assay
Antiproliferative activity against PC3 cells after 72 hrs by MTT assay
[PMID: 17137679]
WM-115 IC50
71.2 μM
Compound: Flavanone
Cytotoxicity against human WM115 cells after 46 hrs by MTT assay
Cytotoxicity against human WM115 cells after 46 hrs by MTT assay
[PMID: 23756061]
WM-115 IC50
71.2 μM
Compound: Flavanone
Cytotoxicity against human WM115 cells by MTT assay
Cytotoxicity against human WM115 cells by MTT assay
[PMID: 25091929]
Clinical Trial
分子量

224.25

Formula

C15H12O2

CAS 号
性状

固体

颜色

Off-white to yellow

中文名称

普罗帕酮EP杂质H

结构分类
初始来源
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 2 years
-20°C 1 year
溶解性数据
细胞实验: 

DMSO 中的溶解度 : 100 mg/mL (445.93 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 4.4593 mL 22.2965 mL 44.5931 mL
5 mM 0.8919 mL 4.4593 mL 8.9186 mL
查看完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 2 years; -20°C, 1 year。-80°C储存时,请在2年内使用, -20°C储存时,请在1年内使用。

  • 摩尔计算器

  • 稀释计算器

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量
=
浓度
×
体积
×
分子量 *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start)

C1

×
体积 (start)

V1

=
浓度 (final)

C2

×
体积 (final)

V2

动物实验:

请根据您的 实验动物和给药方式 选择适当的溶解方案。

以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用
以下溶剂前显示的百分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 方案 一

    请依序添加每种溶剂: 10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.5 mg/mL (11.15 mM); 澄清溶液

    此方案可获得 ≥ 2.5 mg/mL(饱和度未知)的澄清溶液。

    1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;再向上述体系中加入 50 μL Tween-80,混合均匀;然后再继续加入 450 μL 生理盐水 定容至 1 mL

    生理盐水的配制:将 0.9 g 氯化钠,溶解于 ddH₂O 并定容至 100 mL,可以得到澄清透明的生理盐水溶液。
  • 方案 二

    请依序添加每种溶剂: 10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.5 mg/mL (11.15 mM); 澄清溶液

    此方案可获得 ≥ 2.5 mg/mL(饱和度未知)的澄清溶液。

    1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液 中,混合均匀。

    2 g SBE-β-CD(磺丁基醚 β-环糊精)粉末定容于 10 mL 的生理盐水中,完全溶解至澄清透明。
动物溶解方案计算器
请输入动物实验的基本信息:

给药剂量

mg/kg

动物的平均体重

g

每只动物的给药体积

μL

动物数量

由于实验过程有损耗,建议您多配一只动物的量
请输入您的动物体内配方组成:
%
DMSO +
+
%
Tween-80 +
%
Saline
如果您的动物是免疫缺陷鼠或者体弱鼠,建议 DMSO 中的在最后工作液体系中的占比尽量不超过 2%。
方案所需 助溶剂 包括:DMSO ,均可在 MCE 网站选购。 Tween 80,均可在 MCE 网站选购。
计算结果
工作液所需浓度 : mg/mL
储备液配制方法 : mg 药物溶于 μL  DMSO(母液浓度为 mg/mL)。
您所需的储备液浓度超过该产品的实测溶解度,以下方案仅供参考,如有需要,请与 MCE 中国技术支持联系。
动物实验体内工作液的配制方法 : 取 μL DMSO 储备液,加入 μL  μL ,混合均匀至澄清,再加 μL Tween 80,混合均匀至澄清,再加 μL 生理盐水
连续给药周期超过半月以上,请谨慎选择该方案。
请确保第一步储备液溶解至澄清状态,从左到右依次添加助溶剂。您可采用超声加热 (超声清洗仪,建议频次 20-40 kHz),涡旋吹打等方式辅助溶解。
纯度 & 产品资料
参考文献

完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 2 years; -20°C, 1 year。-80°C储存时,请在2年内使用, -20°C储存时,请在1年内使用。

可选溶剂 浓度 溶剂体积 质量 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 4.4593 mL 22.2965 mL 44.5931 mL 111.4827 mL
5 mM 0.8919 mL 4.4593 mL 8.9186 mL 22.2965 mL
10 mM 0.4459 mL 2.2297 mL 4.4593 mL 11.1483 mL
15 mM 0.2973 mL 1.4864 mL 2.9729 mL 7.4322 mL
20 mM 0.2230 mL 1.1148 mL 2.2297 mL 5.5741 mL
25 mM 0.1784 mL 0.8919 mL 1.7837 mL 4.4593 mL
30 mM 0.1486 mL 0.7432 mL 1.4864 mL 3.7161 mL
40 mM 0.1115 mL 0.5574 mL 1.1148 mL 2.7871 mL
50 mM 0.0892 mL 0.4459 mL 0.8919 mL 2.2297 mL
60 mM 0.0743 mL 0.3716 mL 0.7432 mL 1.8580 mL
80 mM 0.0557 mL 0.2787 mL 0.5574 mL 1.3935 mL
100 mM 0.0446 mL 0.2230 mL 0.4459 mL 1.1148 mL
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Flavanone
目录号:
HY-N7128
需求量: